Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion

被引：0
|
作者：
Shoen, Ezra [1 ]
Hou, Angela [1 ]
Zahn, Joseph [1 ]
Friedman, Adam [1 ]
机构：
[1] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2021年 / 20卷 / 03期
关键词：
D O I：
10.36849/IDD.2021.5794
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：336 / 337
页数：2
相关论文
共 50 条
  • [1] Halobetasol Propionate and Tazarotene Combination Lotion 0.01%/0.045% for Psoriasis
    Brownstone, Nicholas D.
    Bhutani, Tina
    Koo, John
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (01) : 21 - 25
  • [2] Halobetasol Propionate and Tazarotene Combination Lotion 0.01%/0.045% for Psoriasis
    Nicholas D. Brownstone
    Tina Bhutani
    John Koo
    Current Dermatology Reports, 2021, 10 : 21 - 25
  • [3] Y Fixed-Combination Halobetasol Propionate and Tazarotene Lotion for Psoriasis in Patients With Skin of Color
    Alexis, Andrew F.
    Desai, Seemal R.
    Han, George
    Jacobson, Abby
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (07) : 735 - 744
  • [4] A novel halobetasol propionate 0.01%/tazarotene 0.045% fixed combination treatment for psoriasis
    Radonjic, Aleksandar
    Evans, Emily L.
    DERMATOLOGIC THERAPY, 2019, 32 (04)
  • [5] Fixed-Combination Halobetasol Propionate and Tazarotene Topical Lotion Decreases Interleukin-17A Levels in Psoriasis
    Draelos, Zoe
    Draelos, Matthew
    Lin, Tina
    Jacobson, Abby
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB169 - AB169
  • [6] Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%-5% Affected Body Surface Area
    Tanghetti, Emil A.
    Bhatia, Neal
    Drew, Scott
    Jacobson, Abby
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (08) : 829 - 836
  • [7] Assessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis
    Kircik, Leon H.
    Papp, Kim A.
    Gold, Linda Stein
    Harris, Susan
    Lin, Tina
    Pillai, Radhakrishnan
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (03) : 279 - 284
  • [8] Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology
    Tanghetti, Emil A.
    Gold, Linda Stein
    Del Rosso, James Q.
    Lin, Tina
    Angel, Arturo
    Pillai, Radhakrishnan
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (04) : 391 - 398
  • [9] Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion
    Desai, Seemal R.
    Alexis, Andrew F.
    Jacobson, Abby
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (10) : 1000 - 1004
  • [10] An Open-Label Pilot Study to Investigate Safety and Efficacy of Fixed Combination Tazarotene 0.045% and Halobetasol Propionate 0.01% Lotion for the Treatment of Scalp Psoriasis
    Ozyurekoglu, Elif
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (11) : 1191 - 1194
12345